Difference between revisions of "Team:ASIJ TOKYO"
| Line 1: | Line 1: | ||
{{Team:ASIJ_TOKYO/css}} | {{Team:ASIJ_TOKYO/css}} | ||
| − | |||
<!-- | <!-- | ||
Solid State by HTML5 UP | Solid State by HTML5 UP | ||
| Line 6: | Line 5: | ||
Free for personal and commercial use under the CCA 3.0 license (html5up.net/license) | Free for personal and commercial use under the CCA 3.0 license (html5up.net/license) | ||
--> | --> | ||
| − | |||
| − | |||
<html> | <html> | ||
<head> | <head> | ||
| + | <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css"> | ||
| + | <style> | ||
<style> | <style> | ||
body {margin:0;} | body {margin:0;} | ||
| Line 59: | Line 58: | ||
.navbar a:hover, .dropdown:hover .dropbtn { | .navbar a:hover, .dropdown:hover .dropbtn { | ||
background-color: #5d70dd; | background-color: #5d70dd; | ||
| − | |||
| − | |||
| Line 72: | Line 69: | ||
min-width: 160px; | min-width: 160px; | ||
box-shadow: 0px 8px 16px 0px rgba(0,0,0,.4); | box-shadow: 0px 8px 16px 0px rgba(0,0,0,.4); | ||
| − | z-index: | + | z-index: 100; |
top: 80px; | top: 80px; | ||
| + | |||
| Line 85: | Line 83: | ||
display: block; | display: block; | ||
text-align: left; | text-align: left; | ||
| − | + | ||
| − | + | ||
} | } | ||
| Line 93: | Line 90: | ||
.dropdown-content a:hover { | .dropdown-content a:hover { | ||
background-color: #ddd; | background-color: #ddd; | ||
| − | |||
| Line 100: | Line 96: | ||
.dropdown:hover .dropdown-content { | .dropdown:hover .dropdown-content { | ||
display: block; | display: block; | ||
| − | |||
| − | |||
position: fixed; | position: fixed; | ||
| Line 137: | Line 131: | ||
</div> | </div> | ||
| + | |||
Revision as of 12:42, 29 October 2017
ASIJ IGEM
IGEM ASIJ_TOKYO
Description
Colorectal cancer remains the second most lethal cancer in the United States, often beginning as benign polyps in the colon and rectum. Despite relative ease of treatment, cases of CRC are usually detected in its late stages, rendering care difficult. CRC results from the mutation of multiple genes involved with the regulation of cell proliferation and DNA repair, with the ASIJ iGEM team focusing primarily on the Wnt pathway. The activation of the Wnt pathway specifically inhibits the degradation of beta-catenin, a protein that triggers the mutation of oncogenes and TSG’s. Through detection of these mutated genes and their subsequent downstream proteins, our team aims to develop an early screening method that can be adapted to a CRC detecting home-kit.
